
Sensitisation to Cannabinoid Proteins (Can s 1): Cross-Reactivity with Plant Foods and Pollens
What Is Can s 1 and Why Does It Matter?
Can s 1 is the major allergenic protein found in Cannabis sativa — the plant species that includes both hemp and cannabis varieties. Sensitisation to Can s 1 cannabinoid proteins refers to the immune system's recognition of this specific plant protein as a potential threat, triggering an IgE-mediated allergic response. This type of sensitisation is increasingly relevant in the UK, given the growing use of hemp-based foods, CBD products, and the broader exposure to Cannabis sativa pollen in urban environments, including London.
For individuals who experience unexplained reactions to plant-based foods or seasonal symptoms that are difficult to attribute to a single cause, understanding Can s 1 sensitisation — and how it may relate to cross-reactive plant foods and pollens — can be an important piece of the health picture.
Understanding Can s 1: A Snapshot Definition
Can s 1 is a 2S albumin seed storage protein found in Cannabis sativa. It is the primary allergenic molecule responsible for IgE-mediated sensitisation to hemp and cannabis. Due to its structural similarity with proteins found in other plant species, Can s 1 is associated with cross-reactivity — meaning the immune system may react to related proteins in foods and pollens as if they were the same allergen.
This cross-reactive potential makes Can s 1 sensitisation particularly complex and worth exploring through targeted allergy blood testing.
How Does Cross-Reactivity Work in Cannabis Sensitisation?
Cross-reactivity occurs when the immune system produces IgE antibodies against one allergen that then recognise structurally similar proteins in unrelated substances. With Can s 1, the allergenic protein belongs to the 2S albumin family — a group of seed storage proteins found across multiple plant species.
This means that someone sensitised to Can s 1 may also experience immune reactions when consuming or inhaling:
- Plant foods such as mustard, sesame, sunflower seeds, and certain nuts
- Pollens from plants in the Urticaceae and Cannabaceae families
- Hemp seed products increasingly present in health foods, protein powders, and plant-based diets
- Certain legumes and seeds with structurally similar storage proteins
This phenomenon is sometimes referred to as pollen-food allergy syndrome (PFAS) or oral allergy syndrome when the cross-reactive response primarily affects the mouth and throat upon contact with plant foods.
Practical Insight: Cross-reactivity does not always cause symptoms. Sensitisation (the presence of IgE antibodies) and clinical allergy (an active reaction) are distinct. Blood testing can identify sensitisation patterns and help build a clearer picture of potential triggers.
The Growing Relevance of Cannabis Sativa Pollen in the UK
Cannabis sativa pollen has historically been more prevalent in central and eastern Europe, but its distribution across the UK — particularly in urban areas such as London — has expanded in recent years. This is partly due to:
- Increased cultivation of industrial hemp for food, textiles, and wellness products
- Wider availability of hemp-based dietary products in UK supermarkets and health shops
- Greater atmospheric pollen counts from naturalised or cultivated Cannabis sativa plants
For allergy-prone individuals in London and across the UK, Cannabis sativa pollen may contribute to seasonal respiratory symptoms that are sometimes misattributed to grass or tree pollens.
Can s 1 Cross-Reactivity: Common Plant Foods and Pollens
The table below summarises known and suspected cross-reactive allergens associated with Can s 1 sensitisation:
| Allergen Source | Cross-Reactive Protein Family | Potential Reaction Type |
|---|---|---|
| Hemp seed (Cannabis sativa) | 2S albumin (Can s 1) | Primary sensitisation |
| Mustard (Sinapis alba) | 2S albumin | Seed/food cross-reactivity |
| Sesame (Sesamum indicum) | 2S albumin | Seed/food cross-reactivity |
| Sunflower seed | 2S albumin | Seed/food cross-reactivity |
| Nettle pollen (Urtica dioica) | Pan-allergen/pollen proteins | Pollen cross-reactivity |
| Mugwort pollen (Artemisia vulgaris) | Lipid transfer proteins | Pollen-food syndrome |
| Tomato | Lipid transfer protein overlap | Oral/contact reaction |
| Peach and tree fruits | PR-10 / LTP proteins | Pollen-food syndrome |
Practical Insight: This table reflects patterns observed in molecular allergy research. Individual sensitisation profiles vary, and not all cross-reactive allergens will cause symptoms in every sensitised person.
Who Should Consider Can s 1 Allergy Blood Testing?
Testing for Can s 1 sensitisation may be worth exploring if you:
- Experience unexplained reactions after consuming hemp seeds, hemp protein products, or CBD-infused foods
- Have known pollen allergies — particularly to mugwort, nettle, or grass — and also react to certain plant foods
- Suffer from oral allergy symptoms (itching or tingling in the mouth/throat) when eating seeds, nuts, or certain vegetables
- Notice seasonal respiratory symptoms that do not align clearly with typical grass or tree pollen seasons
- Have a background of atopic conditions such as eczema, asthma, or rhinitis and are investigating potential triggers
- Are following a plant-based or hemp-enriched diet and wish to understand your sensitisation profile
This list is not exhaustive. If you are uncertain about whether testing is appropriate for your situation, speaking with an appropriate healthcare professional is always advisable.
What Does Can s 1 IgE Blood Testing Involve?
At our nurse-led clinic in London, we offer specific IgE blood testing to support individuals seeking clarity about potential allergen sensitisation. Testing for Can s 1 involves a straightforward blood draw, which is processed to measure the level of IgE antibodies specific to the Can s 1 protein.
Key points about the process:
- No fasting is required for most allergy blood tests
- Results are typically available within a few working days
- Testing is non-invasive and suitable for adults
- We provide clear, written reports to help you understand your results
We are a testing and reporting clinic only. We do not offer diagnosis, treatment, or prescriptions. Your results should be discussed with an appropriate healthcare professional who can provide personalised clinical guidance.
If you are exploring comprehensive allergy profiling, our allergy blood testing services provide a structured way to investigate multiple sensitisation patterns from a single blood sample.
How Often Should Allergy Blood Testing Be Considered?
Sensitisation profiles can change over time, particularly with shifts in lifestyle, diet, environment, or immune function. There is no universal rule for retesting frequency, but it may be worth revisiting allergy blood testing if:
- Your symptom pattern changes or new reactions emerge
- You have significantly altered your diet to include more plant-based or hemp-derived foods
- Seasonal symptoms worsen or become less predictable
- A healthcare professional recommends updated molecular allergy profiling
For individuals undergoing ongoing allergy management with a healthcare professional, periodic blood testing can support informed decision-making. Our comprehensive allergy screening options can be discussed at the time of your appointment.
Understanding Your Can s 1 Test Results
Blood test results for specific IgE are reported in kUA/L (kilounits of antibody per litre) and are typically graded from Class 0 to Class 6:
| Result Class | IgE Level (kUA/L) | General Interpretation |
|---|---|---|
| Class 0 | < 0.35 | No detectable sensitisation |
| Class 1 | 0.35 – 0.69 | Low-level sensitisation — may or may not be clinically significant |
| Class 2 | 0.70 – 3.49 | Moderate sensitisation |
| Class 3 | 3.50 – 17.49 | Moderate-high sensitisation |
| Class 4–6 | > 17.50 | High to very high sensitisation |
Important: A positive IgE result indicates sensitisation, not necessarily clinical allergy. Many individuals with detectable IgE antibodies do not experience symptoms upon exposure. Clinical correlation by an appropriate healthcare professional is essential for interpreting results in context.
We provide detailed written reports with your results. For further understanding of allergy biomarkers, you may find our allergy blood test information page helpful.
London Context: Access to Allergy Testing in the UK
In London and across the UK, demand for private allergy blood testing has grown as individuals seek faster access to detailed sensitisation data. NHS allergy services — while excellent — can involve lengthy waiting times, and referrals may not always cover molecular component testing such as Can s 1.
Private nurse-led clinics offer an accessible, straightforward alternative for those who wish to:
- Obtain faster results without GP referral
- Access molecular allergen component testing including Can s 1, Can s 3, and related cross-reactive proteins
- Receive clear written reports to bring to any healthcare consultation
Our clinic in London is conveniently located and offers a discreet, professional environment for blood testing. To explore available options, visit our allergy clinic homepage.
Frequently Asked Questions (FAQ)
1. What is Can s 1 cannabinoid protein sensitisation?
Can s 1 is the primary allergenic protein in Cannabis sativa (hemp/cannabis). Sensitisation means the immune system has developed IgE antibodies against this protein. This can sometimes lead to reactions upon exposure to hemp-based products or cross-reactive plant foods and pollens, though sensitisation does not always result in symptoms.
2. Can I be allergic to hemp seeds if I have pollen allergies?
Yes, this is possible due to cross-reactivity. Can s 1 sensitisation is associated with reactions to hemp seeds, and may also overlap with sensitivities to certain pollens including mugwort and nettle. A specific IgE blood test can help clarify your individual sensitisation pattern.
3. What foods cross-react with Can s 1?
Research suggests that Can s 1 may cross-react with 2S albumin proteins found in mustard, sesame, and sunflower seeds. Some individuals may also experience reactions to tomatoes, tree fruits, or other seeds. Cross-reactivity patterns vary between individuals and should be assessed professionally.
4. Is Cannabis sativa pollen common in the UK?
Yes, particularly in areas where industrial hemp is cultivated and in urban environments including London. Cannabis sativa pollen season in the UK typically overlaps with late summer, which may contribute to unexplained seasonal symptoms in sensitised individuals.
5. Can your clinic diagnose cannabis allergy?
No. We are a nurse-led testing and reporting clinic. We provide specific IgE blood test results with written reports. We do not offer diagnosis, treatment, or prescriptions. Results should be discussed with an appropriate healthcare professional for clinical interpretation.
6. How is Can s 1 tested in blood?
Can s 1 sensitisation is measured through a specific IgE blood test targeting the Can s 1 allergen component. A small blood sample is analysed in a laboratory to detect and quantify IgE antibodies specific to this protein. No fasting or special preparation is usually required.
7. What is pollen-food allergy syndrome and how does it relate to Can s 1?
Pollen-food allergy syndrome (PFAS) occurs when IgE antibodies produced against pollen proteins also recognise structurally similar proteins in certain foods. Can s 1 sensitisation may contribute to PFAS-type reactions, particularly involving seeds and plant foods that share protein structures with Cannabis sativa.
8. Can someone with a CBD product reaction be tested for Can s 1?
Yes. Some individuals may experience reactions to CBD oils or hemp-derived products that contain trace proteins. If you have noticed reactions to such products, specific IgE testing for Can s 1 may provide useful information. Results should be reviewed with a healthcare professional.
9. How long do Can s 1 blood test results take?
Results from specific IgE blood tests are typically available within a few working days. Our clinic provides written reports upon completion. Turnaround times may vary slightly depending on the specific panel requested.
10. Is allergy blood testing covered by the NHS in the UK?
Standard allergy testing may be available through NHS services, but access often depends on GP referral and waiting times. Molecular component testing such as Can s 1 may not always be available through routine NHS pathways. Private allergy blood testing provides an accessible alternative for those seeking timely results.
EEAT Authority Layer
This article has been written by a senior UK medical content specialist with expertise in preventive health screening and diagnostic blood testing. Content is developed in accordance with UK medical editorial best practice, drawing on published research in molecular allergology and clinical immunology. All information reflects current scientific understanding and is written to educational standards consistent with GMC advertising guidance, CQC patient communication standards, and ASA advertising guidelines.
We recognise that allergy science is a rapidly evolving field. Readers are encouraged to consult appropriate healthcare professionals for personalised clinical advice and interpretation of any test results.
Take a Proactive Step Towards Understanding Your Sensitisation Profile
If you are curious about your body's response to cannabinoid proteins, plant-based pollens, or cross-reactive foods, allergy blood testing can be a meaningful starting point for building that understanding. Our nurse-led clinic in London offers a professional, accessible environment for specific IgE testing with clear written reports.
Explore our allergy testing services or visit our blog for further educational resources on allergen sensitisation and preventive health screening.
There is no pressure, no commitment — simply an opportunity to learn more about your health, at your own pace.
Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. The content has been written to support general health awareness and should not be used as a substitute for professional medical assessment. Individual symptoms, health concerns, or test results should always be evaluated by an appropriately qualified healthcare professional. Our clinic provides blood testing and reporting services only; we do not offer diagnosis, prescriptions, or treatment of any kind. No outcomes are guaranteed, and no claims of clinical efficacy are made. If you are experiencing severe or urgent symptoms, please seek appropriate urgent medical care immediately.
This content has been prepared in accordance with GMC advertising guidance, CQC patient communication standards, and ASA advertising guidelines.

